Dexamethasone-cyclophosphamide pulse therapy in progressive systemic sclerosis

Indian Journal of Dermatology

Volumn 55, Issue 3, 2010, Pages 304-305

  Viswanath, Vishalakshi ^a   Sonavane, Amey D ^a   Doshi, Aditi C ^a   Parab, Mrunal G ^a  

^a Chhatrapati Shivaji Maharaj Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; PENICILLAMINE; VASODILATOR AGENT;

ADOLESCENT; ADULT; BACKACHE; CALCINOSIS; CLINICAL ARTICLE; CUSHINGOID SYNDROME; DISEASE COURSE; DYSPHAGIA; DYSPNEA; FEMALE; FORCED VITAL CAPACITY; HUMAN; HYPERPIGMENTATION; LABORATORY TEST; LETTER; MALE; PHYSICAL EXAMINATION; RAYNAUD PHENOMENON; SIDE EFFECT; SYMPTOM; SYSTEMIC SCLEROSIS; TELANGIECTASIA; TREATMENT RESPONSE; URINARY TRACT INFECTION; WEIGHT GAIN;

EID: 77957740892     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.70697     Document Type: Letter

References (8)

1. Goodfield MJD, Jones SK, Veale DJ. Systemic Sclerosis. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. 7th ed. Oxford, Blackwell Scientific Publications 2004. p. 91-116.
2. Pasricha JS, Ramam M, Shah S. Reversal of systemic sclerosis with dexamethasone pulses. Indian J Dermatol Venereol Leprol 1990;56:40-2.
3. Gupta R. Systemic sclerosis treated with dexamethasone pulse. Indian J Dermatol Venereol Leprol 2003;69:191-2.
4. Ahmad QM, Hassan I, Majid I. Evaluation of dexamethasone pulse therapy in systemic sclerosis. Indian J Dermatol Venereol Leprol 2003;69:76-8.
5. Sharada B, Kumar A, Kakker R, Adya CM, Pande I, Uppal SS, et al. Intravenous dexamethasone pulse therapy in diffuse systemic sclerosis. A randomized placebo-controlled study. Rheumatol Int 1994;14:91-4.
6. Air P, Danieli E, Parrinello G, Antonioli CM, Cavazzana I, Toniati P, et al. Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature with pooled analysis of lung function test results. Clin Exp Rheumatol 2004;22:573-8.
7. White B, Moore WC, Wigley FM, Xiao HQ, Wise RA. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med 2000;132:947-54.
8. Vatwani V, Palta SC, Verma N, Pathak PR, Singh RP. Pulse therapy in scleroderma. Indian Pediatr 1994;31:993-5.